Trisalus Life Sciences, Inc. · NASDAQ:TLSI

Frankenius Equity AB reported a 14.00% stake in Trisalus Life Sciences, Inc. (Schedule 13D/A)

Event Jul 31, 2025 · Filed Aug 4, 2025

Frankenius Equity AB reported a 14.00% stake in Trisalus Life Sciences, Inc., 6,989,748 shares, with active intent on Jul 31, 2025. Filed Aug 4, 2025 (Schedule 13D/A).

Stake
14.00%
Shares
6,989,748
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Frankenius Equity AB14.00%6,989,748
Paul Frankenius14.00%6,989,748

Source

View original at SEC

Related